Routine breast cancer screening for asymptomatic women is well-supported by evidence showing its effectiveness in early detection and mortality reduction.
The provided papers consistently describe mammography screening as a standard, cost-effective tool for early detection and mortality reduction in various populations, supporting the claim without any direct refutation in the evidence base.